S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94

EVRAZ (EVR) Share Forecast, Price & News

GBX 81
+0.11 (+0.14%)
(As of 03/22/2022)
Today's Range
50-Day Range
52-Week Range
13,219 shs
Average Volume
11.92 million shs
Market Capitalization
£1.18 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive EVR News and Ratings via Email

Sign-up to receive the latest news and ratings for EVRAZ and its competitors with MarketBeat's FREE daily newsletter.

EVRAZ logo


EVRAZ plc, together with its subsidiaries, engages in the production and distribution of steel and related products in Russia, the Americas, Asia, Europe, CIS, Africa, and internationally. It operates through four segments: Steel; Steel, North America; Coal; and Other Operations. The company offers steel and value-added products, including infrastructure steel, rails, large-diameter pipes, and oil country tubular goods. It also extracts vanadium ores; processes and produces vanadium products; and mines and enriches iron ore and coal. In addition, the company engages in the energy-generating, shipping, and railway transportation businesses. It offers its products for use in infrastructure and construction projects; and rail, energy, and industrial end-user markets, as well as coke and steel producers. The company was formerly known as Project Savannah PLC and changed its name to EVRAZ plc in October 2011. EVRAZ plc was founded in 1992 and is based in London, the United Kingdom.


See More Headlines

Industry, Sector and Symbol

Year Founded

Sales & Book Value

Annual Sales
£13.49 billion
Cash Flow
GBX 70.40 per share
Book Value
GBX 140.80 per share


Pretax Margin




Outstanding Shares
Free Float
Market Cap
£1.18 billion

Company Calendar

Ex-Dividend for 3/30 Dividend
Dividend Payable
Next Earnings (Estimated)


Overall MarketRank

2.34 out of 5 stars

Analyst Opinion: 3.5Community Rank: 3.2Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 2.5 5 -4 -3 -2 -1 -

EVRAZ (LON:EVR) Frequently Asked Questions

Is EVRAZ a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for EVRAZ in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" EVRAZ stock.
View analyst ratings for EVRAZ
or view top-rated stocks.

When is EVRAZ's next earnings date?

EVRAZ is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for EVRAZ

How often does EVRAZ pay dividends? What is the dividend yield for EVRAZ?

EVRAZ announced a dividend on Friday, February 25th. Shareholders of record on Thursday, March 10th will be paid a dividend of GBX 0.50 per share on Wednesday, March 30th. This represents a yield of 21.84%. The ex-dividend date is Thursday, March 10th. This is an increase from EVRAZ's previous dividend of GBX 0.20. The official announcement can be accessed at this link.
View EVRAZ's dividend history

Is EVRAZ a good dividend stock?

EVRAZ pays an annual dividend of GBX 1.25 per share and currently has a dividend yield of 93.41%. EVR has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of EVRAZ is 0.74%. This payout ratio is at a healthy, sustainable level, below 75%.
View EVRAZ's dividend history.

What price target have analysts set for EVR?

1 brokers have issued twelve-month price objectives for EVRAZ's shares. Their forecasts range from GBX 650 to GBX 650. On average, they expect EVRAZ's stock price to reach GBX 650 in the next twelve months. This suggests a possible upside of 702.5% from the stock's current price.
View analysts' price targets for EVRAZ
or view top-rated stocks among Wall Street analysts.

Who are EVRAZ's key executives?
EVRAZ's management team includes the following people:
  • Mr. Alexey Alexandrovich Ivanov, CEO & Exec. Director (Age 47, Pay $2.91M)
  • Mr. Nikolay Vladimirovich Ivanov, CFO & Exec. Director (Age 50)
  • Ms. Irina Bakhturina, Director of Investor Relations
  • Mr. Sergey Vasiliev, VP of Compliance with Bus. Procedures & Asset Protection (Age 55)
  • Ms. Yanina Staniulenaite, VP of Legal (Age 42)
  • Mr. Vsevolod Sementsov, VP of Corp. Communications (Age 51)
  • Mr. Sergey Sintsov, Vice-Pres of Sales & Logistics (Age 41)
  • Ms. Elena Y. Samsonova, VP of HR (Age 46)
  • Mr. Denis Novozhenov, VP & Head of the Urals Division (Age 48)
  • Mr. Alexey Soldatenkov, VP & Head of the Siberia Division (Age 50)
What other stocks do shareholders of EVRAZ own?

Based on aggregate information from My MarketBeat watchlists, some companies that other EVRAZ investors own include KAZ Minerals (KAZ), Centrica (CNA), British Land (BLND), easyJet (EZJ), Glencore (GLEN), GlaxoSmithKline (GSK), Standard Chartered (STAN), Anglo American (AAL), Lloyds Banking Group (LLOY) and Vodafone Group Public (VOD).

What is EVRAZ's stock symbol?

EVRAZ trades on the London Stock Exchange (LON) under the ticker symbol "EVR."

How do I buy shares of EVRAZ?

Shares of EVR and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is EVRAZ's stock price today?

One share of EVR stock can currently be purchased for approximately GBX 81.

How much money does EVRAZ make?

EVRAZ has a market capitalization of £1.18 billion and generates £13.49 billion in revenue each year.

How many employees does EVRAZ have?

EVRAZ employs 71,591 workers across the globe.

What is EVRAZ's official website?

The official website for EVRAZ is www.evraz.com.

How can I contact EVRAZ?

EVRAZ's mailing address is 5th Fl, 6 St. Andrew Street, LONDON, EC4A 3AE, United Kingdom. The company can be reached via phone at +44-20-78324900.

This page was last updated on 5/16/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.